Involvement of the cAMP/protein kinase A pathway and of mitogen‐activated protein kinase in the anti‐proliferative effects of anandamide in human breast cancer cells
Open Access
- 17 December 1999
- journal article
- Published by Wiley in FEBS Letters
- Vol. 463 (3) , 235-240
- https://doi.org/10.1016/s0014-5793(99)01639-7
Abstract
Anandamide (ANA) inhibits prolactin‐ and nerve growth factor (NGF)‐induced proliferation of human breast cancer cells by decreasing the levels of the 100 kDa prolactin receptor (PRLr) and the high af...Keywords
This publication has 28 references indexed in Scilit:
- VIP and Breast CancerAnnals of the New York Academy of Sciences, 1998
- Priority paper Fibroblast growth factor‐2 has opposite effects on human breast cancer MCF‐7 cell growth depending on the activation level of the mitogen‐activated protein kinase pathwayEuropean Journal of Biochemistry, 1998
- Δ9‐Tetrahydrocannabinol induces apoptosis in C6 glioma cellsFEBS Letters, 1998
- Nerve Growth Factor Is Mitogenic for Cancerous but Not Normal Human Breast Epithelial CellsJournal of Biological Chemistry, 1998
- ‘Endocannabinoids’ and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevanceBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1998
- Tumor‐Necrosis Factor‐α Modulates Mitogen‐Activated Protein Kinase Activity of Epidermal‐Growth‐Factor‐Stimulated MCF‐7 Breast Cancer CellsEuropean Journal of Biochemistry, 1997
- Pharmacology of cannabinoid CB1 and CB2 receptorsPharmacology & Therapeutics, 1997
- Formation and inactivation of endogenous cannabinoid anandamide in central neuronsNature, 1994
- Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosisJournal of Neuroimmunology, 1994
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992